Mouse mutant opens new path for birth defect research

January 16, 2013 by Kenneth M. Noll, University of Connecticut
Andrew Pask, associate professor of Molecular & Cell Biology working in his lab. Credit: Peter Morenus/UConn Photo

(Medical Xpress)—According to the Centers for Disease Control, nearly 3 of every 100 babies in the U.S. are born with a birth defect. Among boys, one of the most common defects is the displacement of the urethral opening in the penis, a condition called hypospadias.

UConn researcher Andrew Pask, an associate professor of , was recently awarded a five-year, $1.75 million grant from the National Institutes of Health to investigate how this abnormality appears in developing , in hopes of preventing its tragic consequences.

"It is the single most common defect that we see," says Pask. "Every instance will require a ."

Because the repair of hypospadias requires surgery, records of its incidence have been kept for many years. "The disturbing thing about hypospadias is that it has increased in incidence by 50 percent in the last 40 years," Pask notes.

The cause of hypospadias and the reason for its increasing appearance are a mystery, but Pask's recent discovery may lead to answers. Pask found a breed of at the Baylor College of Medicine's mouse collection that produces with severe hypospadias. Analyzing its genes, he discovered a mutation in a gene which codes for a long (RNA) that is essential for normal urethral closure and opening placement.

There are other mice with defects in genital development, but Pask's mouse has new characteristics (its "phenotype"). "What's unique about our [mutation] is that it is only affecting urethral closure, the rest of our mouse is completely normal," he says. "This is a much more discrete phenotype." That means the researcher can focus directly on the cause of hypospadias.

Pask's studies indicate that the RNA interacts with an ephrin protein. Ephrin proteins are important in many pathways including  those involving tissue closure, as in the urethra and the oral palate.

The DNA encoding this long, non-coding RNA is surrounded by sites controlling RNA production that respond to the sex hormones estrogen and androgen. This suggests that production of this RNA is an important step in hormonal control of genital development.

Chemicals that mimic sex hormones might affect the production of this essential RNA – chemicals like those increasingly found in the environment from industrial and agricultural processes. This might explain why the incidence of hypospadias has increased recently in developed countries. A mother's  exposure to such chemicals might affect the developing male fetus in the two weeks critical to the urethral closure process. "So you have to be exposed in that very narrow window to have an effect," Pask explains.

Pask has his work cut out for him. "It is clear that [the developmental pathway] is going to be extremely complex," he says. His mouse breed is a unique tool to reveal the genes involved in the urethral development pathway. "We are hoping that we can use it as a tool to figure out what these genes are down the cascade and how they are responding to estrogen."

Explore further: Surgeons examine hypospadias repair efficacy for patients with differing anatomies

Related Stories

Surgeons examine hypospadias repair efficacy for patients with differing anatomies

June 15, 2011
A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.

Mouse experiments show fickle functions for folic acid

October 6, 2011
(Medical Xpress) -- Dietary folic acid helps prevent a subset of neurological birth defects in humans -- although the precise mechanism by which it prevents them is unclear. Now, researchers have found that certain genetic ...

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.